Cell 187(15):38293853 [DOI] [PMC free article] [PubMed] [Google Scholar] 17.Wolfe MM, Boylan MO, Chin WW (2025) Glucose-dependent insulinotropic polypeptide in incretin physiology: role in health and disease
Red-flag symptoms (rare but serious, per Mayo Clinic): Persistent severe abdominal pain Signs of pancreatitis Gallbladder issues Seek medical care immediately if these occur
However, our Nurse Practitioner is on-site and offers prescribing Hormone Replacement Therapy, and other Functional Medicines such as LDN and Rifaximin
It increases insulin secretion, decreases glucagon secretion, slows gastric emptying, and reduces appetite, leading to better blood sugar control and weight loss
If Eli Lilly files for FDA approval in 2026 and the process runs smoothly, MHRA authorisation could follow by late 2027 or early 2028
Lebedev, A